Parenteral Nutrition Bags Market Size & Growth Forecast 2027–2036, By Segments (Capacity, End-use, Type, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Parenteral Nutrition Bags Market size was more than USD 887.24 Million in 2026 and is set to grow at 7.21% CAGR between 2027 and 2036, reaching USD 1.78 Billion by 2036. The industry revenue for 2027 is assessed at USD 941.54 Million.
Get more details on this report
Request Free Sample ReportParenteral Nutrition Bags Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific held 34.24% in 2026, supported by expanding healthcare infrastructure, rising healthcare expenditure, and broader access to specialized nutritional therapies.
- Growing hospital capabilities, increasing chronic and critical illnesses, greater awareness of nutritional support, and investments in medical facilities are strengthening regional demand.
Segment Momentum
- The 150 - 500 ml segment held a 57.79% share in 2026 due to its broad clinical use, dosing flexibility, and suitability for routine nutritional therapy.
- The 500 - 1,500 ml segment is expanding as healthcare providers seek higher-volume nutritional support, improved efficiency, and fewer bag replacements for intensive care needs.
Market Expansion Drivers
- Rising chronic diseases and metabolic disorders increasing demand for clinical nutrition support systems
- Growing geriatric population driving hospital-based parenteral nutrition adoption globally
- Innovations in sterile packaging materials improving safety and efficiency of nutrition delivery systems
Leading Market Participants
- Prominent companies in the parenteral nutrition bags market include Baxter International Inc. (USA), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Grifols S.A. (Spain), GVS S.p.A. (Italy), Technoflex (France), Diffuplast S.r.l. (Italy), HEMEDIS GmbH (Germany), Valmed s.r.l (Italy)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 887.24 Million
- 2027 Estimated Market Size: USD 941.54 Million
- Projected Market Size: USD 1.78 Billion by 2036
- Growth Forecast: 7.21% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: 150 - 500 Ml (Capacity) | Hospitals (End-use) | Multi-chambered Bags (Type) | Ethylene Vinyl Acetate (EVA) (Material)
- Emerging Opportunity Segment: 500 - 1,500 Ml (Capacity) | Pharmacies & Compounding Service Providers (End-use) | Multi-chambered Bags (Type) | Ethylene Vinyl Acetate (EVA) (Material)
Market Growth Drivers and Industry Trends
Rising chronic diseases and metabolic disorders increasing demand for clinical nutrition support systems
The growing burden of chronic illnesses and metabolic disorders is increasing the number of patients who may require nutritional support when normal oral or enteral feeding is inadequate, supporting the parenteral nutrition bags market. Patients undergoing intensive treatment, recovering from major procedures, or experiencing impaired gastrointestinal function may require intravenous delivery of nutrients to maintain energy intake and support recovery. Parenteral nutrition systems allow healthcare providers to administer combinations of carbohydrates, amino acids, lipids, electrolytes, vitamins, and other nutritional components according to individual clinical requirements. As hospitals manage increasingly complex patient populations, reliable packaging becomes essential for safely preparing, storing, transporting, and administering these nutrient formulations. Greater emphasis on individualized clinical nutrition is consequently increasing the role of specialized bags within hospital-based nutrition support workflows.
Growing geriatric population driving hospital-based parenteral nutrition adoption globally
Population aging is increasing the number of older patients facing conditions that can impair nutritional intake, swallowing ability, gastrointestinal function, or recovery from major illness, strengthening demand in the parenteral nutrition bags market. Elderly patients may require nutritional intervention during prolonged hospitalization, postoperative recovery, severe illness, or periods when conventional feeding routes cannot adequately meet nutritional needs. Parenteral nutrition provides clinicians with a controlled method of delivering essential nutrients when gastrointestinal feeding is unsuitable or insufficient. The needs of older patients can also require careful formulation and monitoring because of differences in metabolic status, comorbidities, and tolerance to nutritional interventions. As hospitals expand supportive-care capabilities for aging populations, dependable sterile nutrition-delivery systems are becoming increasingly important within multidisciplinary patient management.
Innovations in sterile packaging materials improving safety and efficiency of nutrition delivery systems
Advances in sterile packaging materials and bag design are improving the usability, compatibility, and safety of intravenous nutrition systems, supporting the parenteral nutrition bags market through product innovation. Modern bags can be engineered to provide stronger barriers against oxygen, moisture, light, and contamination while maintaining compatibility with complex nutrient formulations. Improvements in multilayer films, seals, ports, and container configurations can also reduce leakage risks and simplify preparation and administration procedures in clinical environments. Material development is particularly important for formulations containing sensitive nutrients that may be affected by environmental exposure or interactions with packaging components. As healthcare providers place greater emphasis on medication and nutrition safety, manufacturers are investing in packaging designs that support sterile handling, reliable storage, efficient administration, and integration with hospital preparation workflows.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising chronic diseases and metabolic disorders increasing demand for clinical nutrition support systems | 2% | High | North America, Europe | High | Near Term |
| Growing geriatric population driving hospital-based parenteral nutrition adoption globally | 1.5% | High | Europe, Asia Pacific | High | Mid Term |
| Innovations in sterile packaging materials improving safety and efficiency of nutrition delivery systems | 1% | High | North America, Europe | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Asia Pacific (Largest & Fastest-Growing Region)
Asia Pacific led the parenteral nutrition bags market with a share of 34.24% in 2026 and is also projected to remain the fastest-growing region, supported by expanding healthcare infrastructure, increasing access to specialized nutritional therapies, and a growing need for clinical nutrition among patients who cannot receive adequate nourishment through conventional oral or enteral routes. Rising healthcare expenditure, improvements in hospital capabilities, and the broader adoption of advanced patient-care practices are strengthening demand across the region. In addition, the increasing prevalence of chronic and critical illnesses, along with greater awareness of nutritional support in hospital settings, is encouraging healthcare providers to adopt reliable parenteral nutrition solutions. Growing investments in medical facilities and improvements in healthcare delivery are further reinforcing the region's long-term market potential.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Hospital Care OptimizationThe U.S. prioritizes parenteral nutrition bags that improve medication safety, sterility, and workflow efficiency in hospitals. Healthcare providers increasingly adopt ready-to-use nutrition systems that support critical care and home infusion services.
Germany 🇩🇪
Sterile Packaging ExcellenceGermany emphasizes high-quality parenteral nutrition bags supported by advanced pharmaceutical manufacturing and strict quality standards. Manufacturers continue enhancing packaging integrity and compatibility with automated hospital pharmacy systems.
Japan 🇯🇵
Clinical Nutrition SupportJapan focuses on parenteral nutrition bags designed for aging populations and specialized clinical care. Japanese healthcare providers value reliable sterile packaging that improves treatment consistency while supporting efficient hospital operations.
South Korea 🇰🇷
Modern Infusion SystemsSouth Korea is strengthening parenteral nutrition bag adoption through healthcare modernization and pharmaceutical innovation. Domestic manufacturers emphasize high-quality sterile packaging that aligns with advanced hospital practices and export opportunities.
France 🇫🇷
Patient Safety EmphasisFrance supports parenteral nutrition bags that enhance patient safety and reduce preparation complexity within healthcare facilities. Manufacturers prioritize dependable packaging solutions that meet stringent pharmaceutical and clinical quality expectations.
Italy 🇮🇹
Hospital Pharmacy EfficiencyItaly continues integrating parenteral nutrition bags into hospital nutrition management and specialized care services. Italian healthcare providers favor reliable packaging systems that simplify preparation while maintaining sterility and treatment quality.
Segment Leadership and Growth Trends
Parenteral Nutrition Bags Market Share (%), by Capacity, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportCapacity Segment Analysis: 150 - 500 Ml (Largest Segment) vs 500 - 1,500 Ml (Fastest-Growing Segment)
The 150 - 500 ml capacity segment dominated the parenteral nutrition bags market with a 57.79% share in 2026. Its leadership is primarily driven by widespread use in routine nutritional therapy where controlled nutrient delivery and dosing flexibility are important. These bags are commonly utilized across a broad range of patient populations, making them a practical and frequently selected option in clinical settings.
The 500 - 1,500 ml capacity segment is expected to experience the fastest growth due to increasing demand for higher-volume nutritional support in patients requiring extended or intensive care. The ability to accommodate larger nutrient formulations while reducing the need for frequent bag replacements enhances operational efficiency for healthcare providers. Growing emphasis on personalized nutrition management is also contributing to the segment’s expansion.
End-use Segment Analysis: Hospitals (Largest Segment) vs Pharmacies & Compounding Service Providers (Fastest-Growing Segment)
Hospitals represented the largest end-use segment in 2026. Their leading position is supported by the high volume of patients requiring parenteral nutrition, particularly in critical care, surgical recovery, and specialized treatment settings. Hospitals possess the infrastructure, clinical expertise, and monitoring capabilities necessary to administer complex nutritional therapies, making them the primary consumers of parenteral nutrition bags.
The pharmacies & compounding service providers segment is emerging as the fastest-growing category as healthcare systems increasingly emphasize customized nutrition solutions. These providers play a crucial role in preparing patient-specific formulations and supporting outpatient care models. Rising demand for personalized therapies and specialized compounding services is expected to drive greater adoption within this segment.
Type Segment Analysis: Multi-chambered Bags (Largest & Fastest-Growing Segment)
The multi-chambered bags segment dominated the parenteral nutrition bags market and was the largest as well as the fastest-growing segment in 2026. Its strong market position is attributed to the ability to store multiple nutritional components separately until administration, helping preserve ingredient stability and extend product usability. This design also simplifies preparation procedures and reduces the risk of contamination during handling. Growing demand for efficient and ready-to-use nutritional delivery systems is further strengthening the adoption of multi-chambered bags. Healthcare providers increasingly favor solutions that improve workflow efficiency, enhance patient safety, and support accurate nutrient administration, making multi-chambered configurations a preferred option across a variety of care settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Capacity | 150 - 500 Ml, 500 - 1,500 Ml, 50 - 150 Ml, 1,500 - 3,500 Ml, Others | 150 - 500 Ml | 500 - 1,500 Ml |
| End-use | Pharmaceutical Companies, Hospitals, Pharmacies & Compounding Service Providers | Hospitals | Pharmacies & Compounding Service Providers |
| Type | Single-chamber Bags, Dual-chamber Bags, Multi-chambered Bags | Multi-chambered Bags | Multi-chambered Bags |
| Material | Polyvinyl Chloride (PVC), Ethylene Vinyl Acetate (EVA), Polypropylene (PP), Others | Ethylene Vinyl Acetate (EVA) | Ethylene Vinyl Acetate (EVA) |
Competitive Landscape and Market Positioning
Top players in the parenteral nutrition bags market:
- Baxter International, Inc. (USA)
- B. Braun Melsungen AG (Germany)
- Fresenius Kabi AG (Germany)
- Grifols S.A. (Spain)
- GVS S.p.A. (Italy)
- Technoflex (France)
- Diffuplast S.r.l. (Italy)
- HEMEDIS GmbH (Germany)
- Valmed s.r.l (Italy)
Manufacturers in the parenteral nutrition bags market are increasingly competing around material performance, formulation compatibility, and supply reliability as healthcare providers seek safer and more efficient solutions for complex nutritional therapies. Established suppliers continue to strengthen their positions through improvements in multilayer bag designs, barrier properties, and manufacturing consistency, while emerging participants are creating pressure through specialized offerings focused on reducing contamination risks and improving handling efficiency. Regulatory compliance, sterilization capabilities, and the ability to support evolving clinical requirements are becoming important differentiators, raising entry barriers and encouraging suppliers to invest in process innovation rather than competing solely on product availability.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. (USA) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Fresenius Kabi AG (Germany) | |||||||
| Grifols S.A. (Spain) | |||||||
| GVS S.p.A. (Italy) | |||||||
| Technoflex (France) | |||||||
| Diffuplast S.r.l. (Italy) | |||||||
| HEMEDIS GmbH (Germany) | |||||||
| Valmed s.r.l (Italy) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| GVS | May-22 | GVS acquired 100% of the share capital of Haemotronic, an Italian manufacturer of medical components and bags with production facilities in Italy and Mexico. The acquisition expanded GVS's medical bag portfolio, strengthened manufacturing capabilities, and enhanced its presence across the European and North American healthcare markets. |
| Baxter | Aug-19 | Baxter launched Finomel, a ready-to-use triple-chamber parenteral nutrition bag, across Europe. The introduction expanded the company's portfolio of premixed parenteral nutrition formulations, providing healthcare providers with additional clinically ready nutrition options for adult patients and reinforcing Baxter's position in the parenteral nutrition market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Parenteral Nutrition Bags Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Bag Port Configuration | Single-Port, Dual-Port, Multi-Port |
| Sterilization Method | Steam Sterilization, Ethylene Oxide Sterilization, Radiation Sterilization |
| Application Setting | Neonatal & Pediatric Care, Adult Acute Care, Home Parenteral Nutrition, Long-Term Care |
Parenteral Nutrition Bags Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Home Parenteral Nutrition Adoption Assessment |
|
| Hospital Procurement and Tender Intelligence |
|
| Healthcare Reimbursement and Funding Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the parenteral nutrition bags market?
How is the parenteral nutrition bags industry size expected to evolve during the forecast period?
How are evolving clinical nutrition needs driving demand for parenteral nutrition bags?
Why are sterile packaging innovations becoming a strategic focus in the parenteral nutrition bags market?
Why does the 150 - 500 ml capacity segment lead the parenteral nutrition bags market?
How is the 500 - 1,500 ml capacity segment supporting growth in the parenteral nutrition bags market?
Why does Asia Pacific lead the parenteral nutrition bags market?
What is driving continued growth of parenteral nutrition bags in Asia Pacific?
Who are the leading players in the parenteral nutrition bags landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization